Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Rectal cancer
Stage/Subtype:  stage II rectal cancer
Trial Type:  Treatment
Results 1-17 of 17 for your search:
Start Over
Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients with Locally Advanced Rectal Cancer Undergoing Surgery
Status: Active
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: N1048, NCI-2012-00234, CDR0000715321, NCCTG-N1048, PN1048_A11PAMDREVW01, NCT01515787
Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers
Status: Active
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: CDR0000577892, NCI-2015-01484, NCI-2014-01372, SINGAPORE-07-32-LGI, SINGAPORE-ICR-02, ICR-02, SINGAPORE-ASCOLT, NCT00565708
Cyclodextrin-Based Polymer-Camptothecin CRLX10, Capecitabine, and Radiation Therapy before Surgery in Treating Patients with Locally Advanced Rectal Cancer
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: LCCC 1315, NCI-2014-00897, NCT02010567
Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin before Surgery in Treating Patients with Stage II-III Rectal Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 3R-12-2, NCI-2013-01069, 3C-12-2, HS-12-00726, ML28263, NCT01871571
Chemotherapy before or after Chemoradiation Followed by Surgery or Non-operative Management in Treating Patients with Previously Untreated Stage II-III Rectal Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 13-213, NCI-2013-02356, NCT02008656
Chemoradiation or Brachytherapy before Surgery in Treating Patients with Rectal Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: J1360, NCI-2014-00731, NA_00082167, NA_00082167 / CIR00008177, NCI-2014-00125, NCT02017704
Neuromodulation with InterStim Device in Reducing Bowel Dysfunction after Surgery in Patients with Rectal Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 14-100, NCI-2014-01368, NCT02163187
Regorafenib in Reducing Recurrence in Patients with Non-metastatic Rectal Cancer Who Have Completed Curative-Intent Treatment
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: I 246813, NCI-2014-02202, ONC-2013-036, NCT02287727
Low Dose Whole Pelvic Radiation Therapy and Fluorouracil, Leucovorin Calcium, and Oxaliplatin in Treating Patients with Newly Diagnosed Stage IIIA-IIIB Rectal Cancer That Can Be Removed by Surgery
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: GCC 1314, NCI-2015-02142, 1314GCC, 15654748, HP-00060641, NCT02319304
Trametinib, Fluorouracil, and Radiation Therapy before Surgery in Treating Patients with Stage II-III Rectal Cancer
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: OSU-12054, NCI-2012-02158, 2012C0086, NCT01740648
Radiation Therapy and Fluorouracil Followed by Combination Chemotherapy before and after Surgery in Treating Patients with Locally Advanced Rectal Cancer
Status: Enrolling by invitation
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: MCC-14-10491, NCI-2014-02089, NCT02270606
Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: BB-005, NCI-2016-00615, NCT02496065
Niclosamide in Treating Patients with Colon Cancer That Can Be Removed by Surgery
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: Pro00066964, NCI-2016-01245, NCT02687009
Hand Assisted Versus "Pure" Laparoscopic Assisted Proctectomy for Rectal Cancer
Status: Active
Phase: No phase specified
Type: Health services research, Treatment
Age: 18 and over
Trial IDs: MITT02, NCI-2014-02392, NCT00651677
Chinese Herbal Formulation PHY906 in Reducing Side Effects Caused by Capecitabine and Radiation Therapy in Patients with Locally Advanced Rectal Cancer
Status: Active
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 1404013708, NCI-2014-01560, NCT02178644
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Active
Phase: No phase specified
Type: Diagnostic, Treatment
Age: 18 and older
Trial IDs: PP PLR 03, NCI-2015-01386, NCT02205307
Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Status: Not yet active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: S1609, NCI-2016-01041, NCT02834013
Start Over